Lien vers Pubmed [PMID] – 24759827
Clin. Infect. Dis. 2014 Aug;59(3):435-45
Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency virus (HIV)-infected patients with tuberculosis. A better understanding of causes and determinants of death may lead to new strategies to further enhance survival.